Federal Supply Schedule 36F79721D0246

Award Date 9/15/21
Last Date to Order 9/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,980,000.00 and a period of performance that runs through January 1, 2026. The contracted products and services under this multiple award FSS-61-IB schedule include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Llorens Pharmaceutical International...
This Federal Supply Schedule (FSS) contract, awarded to First Nation Group LLC, a veteran-owned and service-disabled veteran-owned small business, provides drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12). The $225,000.00 contract has a performance period from September 15, 2024, to September 14, 2029. The price list includes a variety of pharmaceutical products, such as Cyclobenzaprine HCL...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
The Federal Supply Schedule (FSS) contract award 36F79724D0047 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,188,000.00 and a period of performance through December 31, 2028. The contract was awarded to Nnodum Pharmaceuticals Corp, a minority-owned and SBA-certified 8(a) small disadvantaged business. The contract is for the procurement of 65 I B, DRUGS,...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Verity Pharmaceuticals, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB schedule, with a contract ceiling value of $225,000.00 and a period of performance through November 30, 2026. The...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12, provides Drugs, Pharmaceuticals, and Hematology Related Products. The prime contractor is Tris Pharma Inc., a self-certified small disadvantaged business manufacturer of goods, with a contract ceiling value of $28,000,000 over the period of performance from September 1, 2023 to August 31, 2028. The contract is a multiple award vehicle, with no set-asides used. While the...

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a division of the U.S. Department of Veterans Affairs, to Tolmar, Inc., a foreign-owned, self-certified small disadvantaged business manufacturer of goods.

The contract, valued at a ceiling of $2,290,070.00, is for the provision of drugs, pharmaceuticals, and hematology-related products under the FSS-61-IB Pharmaceuticals and Drugs schedule. The period of performance runs from September 15, 2021 through September 14, 2026. As an FSS contract, this is a multiple award vehicle, meaning other qualified vendors may also be awarded contracts under the same schedule. The contract does not have any set-aside requirements. Based on the contract description, the primary purpose is to provide the VA's VISN 12 network with a diverse selection of pharmaceutical and drug products to support their healthcare operations and serve the veteran population within their region.

Generated 3/6/25, 10:04 AM